Myrexis Cmn Stk Valuation
| MYRXDelisted Stock | USD 0 0.00 0.00% |
Myrexis Cmn seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Myrexis Cmn Stk from analyzing the firm fundamentals such as Shares Owned By Institutions of 1.25 %, current valuation of 3.93 M, and Return On Equity of -0.26 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Myrexis Cmn's price fluctuation is very steady at this time. Calculation of the real value of Myrexis Cmn Stk is based on 3 months time horizon. Increasing Myrexis Cmn's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Myrexis Cmn is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Myrexis Pink Sheet. However, Myrexis Cmn's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.001 | Real 7.97E-4 | Hype 0.00125 |
The intrinsic value of Myrexis Cmn's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Myrexis Cmn's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Myrexis Cmn Stk helps investors to forecast how Myrexis pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Myrexis Cmn more accurately as focusing exclusively on Myrexis Cmn's fundamentals will not take into account other important factors: Myrexis Cmn Total Value Analysis
Myrexis Cmn Stk is now projected to have valuation of 3.93 M with market capitalization of 4.14 M, debt of 0, and cash on hands of 1.21 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Myrexis Cmn fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.93 M | 4.14 M | 0 | 1.21 M |
Myrexis Cmn Asset Utilization
One of the ways to look at asset utilization of Myrexis is to check how much profit was generated for every dollar of assets it reports. Myrexis Cmn Stk secures a negative usage of assets of -0.15 %, losing $0.001506 for each dollar of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each dollar of assets it secures. Strictly speaking, asset utilization of Myrexis Cmn Stk shows how discouraging it operates for each dollar spent on its assets.Myrexis Cmn Ownership Allocation
Myrexis Cmn Stk maintains a total of 34.48 Million outstanding shares. Roughly 98.75 % of Myrexis Cmn outstanding shares are held by general public with 1.25 % by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Myrexis Cmn Profitability Analysis
Net Loss for the year was (11.62 M) with profit before overhead, payroll, taxes, and interest of 0.About Myrexis Cmn Valuation
Our relative valuation model uses a comparative analysis of Myrexis Cmn. We calculate exposure to Myrexis Cmn's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Myrexis Cmn's related companies.Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 1 people.
8 Steps to conduct Myrexis Cmn's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Myrexis Cmn's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Myrexis Cmn's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Myrexis Cmn's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Myrexis Cmn's revenue streams: Identify Myrexis Cmn's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Myrexis Cmn's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Myrexis Cmn's growth potential: Evaluate Myrexis Cmn's management, business model, and growth potential.
- Determine Myrexis Cmn's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Myrexis Cmn's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Myrexis Cmn Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Retained Earnings | -128.5 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Myrexis Pink Sheet
If you are still planning to invest in Myrexis Cmn Stk check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Myrexis Cmn's history and understand the potential risks before investing.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |